Claims Analysis
Total Claims: 12
Claim 1
Independent Claim
151 words
A method for diagnosing the presence of tumors or bacterial infections having β-glucuronidase activity, in a patient, comprising: injecting a non-toxic conjugated glucuronide of an aglycone, which aglycone, in the free state thereof, differs in color, color intensity, or fluorescence from the conjugated glucuronide thereof; collecting the urine of the patient for a period of time sufficient to permit most of the injected glcuronide to be expelled from the body if it is not retained therein; and determining the amount of glucuronide present in the collected urine by deconjugating the glucuronide in a sample of the urine and comparing the color, color intensity or fluorescence of the aglycone with a standard curve, thus indicating the quantity of aglycone in the sample; whereby, if it appears that a substantial amount of glucuronide has been retained in the body, this is a positive indication of a tumor or bacterial infection having β-glucuronidase activity.
Claim 2
Independent Claim
151 words
A method for diagnosing the presence of tumors or bacterial infections having β-glucuronidase activity, in a patient, comprising: injecting a non-toxic conjugated glucuronide of an aglycone, which aglycone, in the free state thereof, differs in color, color intensity, or fluorescence from the conjugated glucuronide thereof; collecting the urine of the patient for a period of time sufficient to permit most of the injected glcuronide to be expelled from the body if it is not retained therein; and determining the amount of glucuronide present in the collected urine by deconjugating the glucuronide in a sample of the urine and comparing the color, color intensity or fluorescence of the aglycone with a standard curve, thus indicating the quantity of aglycone in the sample; whereby, if it appears that a substantial amount of glucuronide has been retained in the body, this is a positive indication of a tumor or bacterial infection having β-glucuronidase activity.
Claim 3
Dependent Claim
13 words
A method in accordance with claim 1, wherein said glucuronide is phenolphthalein glucuronide.
Claim 4
Independent Claim
21 words
A method in accordance with claims 1 or 2, wherein the urine is collected for a period of twenty four hours.
Claim 5
Dependent Claim
42 words
A method in accordance with claim 2, wherein the urine is analyzed by taking a sample of the urine, deconjugating the phenolphthalein glucuronide, alkalinizing and comparing the color intensity with a standard curve, thus indicating the quantity of phenolphthalein in the sample.
Claim 6
Dependent Claim
19 words
A method in accordance with claim 4, wherein said glucuronide is deconjugated by treating with a concentrated mineral acid.
Claim 7
Dependent Claim
31 words
A method in accordance with claim 1, wherein prior to or concurrent with administration of the glucuronide a hyperacidifying agent is added to hyperacidify any tumor cells which may be present.
Claim 8
Dependent Claim
48 words
A process in accordance with claim 1 or claim 6, wherein previous to or concurrent with administration of the glucuronide an alkalinizing agent is added in an amount sufficient to maintain the pH level of the non-tumor tissues of the patient at approximately 7.4 during the glucuronide treatment.
Claim 9
Dependent Claim
15 words
A process in accordance with claim 6, wherein said hyperacidifying agent comprises a hyperglycemic agent.
Claim 10
Dependent Claim
15 words
A process in accordance with claim 7, wherein said hyperacidifying agent comprises a hyperglycemic agent.
Claim 11
Dependent Claim
27 words
A process in accordance with claim 8 or claim 9, wherein the hyperglycemic agent is selected from the group consisting of glucose, fructose, galactose, lactose and glucogan.
Claim 12
Dependent Claim
18 words
A process in accordance with claim 7, wherein said alkalinizing agent comprises an alkali metal bicarbonate or citrate.